Infections and Psoriasis Treatment: More "Real-World" Data Needed with Critical Appraisal
- PMID: 28110708
- DOI: 10.1016/j.jid.2016.10.022
Infections and Psoriasis Treatment: More "Real-World" Data Needed with Critical Appraisal
Abstract
Data from the Spanish registry BIOBADADERM suggest that the risks of any infectious episode in patients treated with biologics are limited, not exceeding the risks observed with a conventional treatment such as cyclosporine. The registry lacked enough statistical power to analyze risks for severe infections. These should be the focus of further research, although the difficulties of "real-world" data analysis should not be trivialized.
Copyright © 2016 The Author. Published by Elsevier Inc. All rights reserved.
Comment on
-
Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry.J Invest Dermatol. 2017 Feb;137(2):313-321. doi: 10.1016/j.jid.2016.08.034. Epub 2016 Sep 25. J Invest Dermatol. 2017. PMID: 27677836
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical